HIMS Stock Analysis: Buy, Sell, or Hold?
HIMS - Hims & Hers Health, Inc.
$27.08
0.88 (3.38%)
▲
5d:
-2.47%
30d:
+5.56%
90d:
+22.18%
BUY
HIGH Confidence
Analysis Updated: Jun 5, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Smart Money Distribution
None View Scanner →
Strength: 8.1/10
Get Alerted When HIMS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: HIMS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: HIMS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$18.08
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$11.22
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HIMS is currently trading at $27.07, which is considered fair relative to its 30-day fair value range of $24.06 to $27.89. From a valuation perspective, the stock is trading at a premium (Forward PE: 50.8) compared to its historical average (41.5). At these levels, the market is pricing in 6.9% annual earnings growth.
Technical Outlook: Technically, HIMS is in a downtrend. Immediate support is located at $23.30, while resistance sits at $29.82. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: HIMS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HIMS is in a downtrend. Immediate support is located at $23.30, while resistance sits at $29.82. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: HIMS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$24.06 -
$27.89
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.7%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.4%)
- NEUTRAL: Near Wall St target ($26.61)
- BULLISH: Expecting earnings turnaround to 6.9% growth with 3.8% revenue growth
Trading Range Analysis
30-Day Trading Range
$24.06 -
$27.89
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$23.30
Resistance Level
$29.82
Current Trend
Downtrend
Technical data as of
Jun 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
50.76
Wall Street Target
$26.61
(+1.6%)
Revenue Growth (YoY)
3.8%
Earnings Growth (YoY)
-17.4%
Profit Margin
-0.6%
Valuation Premium vs History
+6.9% premium
PE vs Historical
50.8 vs 41.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.9%
(market-implied from PE analysis)
1-Year Target
$28.00
(+7%)
2-Year Target
$29.93
(+14%)
3-Year Target
$31.99
(+22%)
3-Yr Target (if PE normalizes)
(PE: 51→42)
PE COMPRESSION
$26.16
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: June 08, 2026 11:43 AM ET
Data refreshes hourly during market hours. Next update: 12:43 PM
Data refreshes hourly during market hours. Next update: 12:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HIMS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
16
Sells
Net
INSIDERS SELLING
Recent Transactions
Soleil Boughton
SELL
9463 shares
2026-04-20
Oluyemi Okupe
SELL
19645 shares
2026-04-20
Oluyemi Okupe
SELL
18005 shares
2026-04-17
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$193 | 64 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 59 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 59 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 58 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
Advanced HIMS Option Strategies
Professional options setups generated by AI based on today's HIMS price and gamma walls.
